🇺🇸 FDA

Drug profile · INN

sitagliptin and metformin hydrochloride

SITAGLIPTIN AND METFORMIN HYDROCHLORIDE

approved
US status
approved
Patents linked
0
News articles
0

Quick answer

sitagliptin and metformin hydrochloride (SITAGLIPTIN AND METFORMIN HYDROCHLORIDE) is an FDA-listed pharmaceutical active ingredient. Current US regulatory status: approved.

Key facts

INN sitagliptin and metformin hydrochloride
Brand SITAGLIPTIN AND METFORMIN HYDROCHLORIDE
Formulation TABLET

Frequently asked questions

What is sitagliptin and metformin hydrochloride?

sitagliptin and metformin hydrochloride (SITAGLIPTIN AND METFORMIN HYDROCHLORIDE) is an FDA-listed pharmaceutical active ingredient. Current US regulatory status: approved.

What is the brand name for sitagliptin and metformin hydrochloride?

SITAGLIPTIN AND METFORMIN HYDROCHLORIDE is a marketed brand name for sitagliptin and metformin hydrochloride. Check FDA Drugs@FDA for the current US label holder and prescribing information.

What is the US approval status of sitagliptin and metformin hydrochloride?

sitagliptin and metformin hydrochloride has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.